CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Rules of Retirement Best Funds Best Places to Retire Fortune Brainstorm Tech Apple 2.0 Blog Big Tech Blog Sectors and Stocks Tech Talk Resource Guide Small Business Makeovers Questions & Answers Small Business Video 100 Best Places to Launch FSB 100 Fortune Small Business Fortune 500 Brainstorm Tech Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts
Trends
By Lawrence A. Armour

(FORTUNE Magazine) – The cost of prescription drugs soared to $154 billion last year, up 17% from 2000. Pundits have blamed rising R&D outlays, relentless TV ads, and greedy pharma conglomerates for the jump. But we wonder...has anyone considered pens as the culprit?

In a recent survey of doctors' offices, FORTUNE unearthed a dazzling array of plastic, chrome, and wood pens emblazoned with everything from Allegra and Aricept to Zithromax and Zoloft. (Our favorite: a sleek silver and gray beauty, courtesy of Viagra.) Though it's impossible to track drug pen expenditures, as Henry Morgan of PENSRUS on Staten Island notes, "Every time a drug company comes out with a new drug, they put the name on a pen and get it to as many doctors as they can."

On July 1 the drug industry will launch a new (voluntary) code of conduct banning gifts like basketball tickets and Tahitian trips, but small giveaways will still be allowed. Our prediction? Big Pharma will likely come down with a new case of pen pushing.

--Lawrence A. Armour